Literature DB >> 15309347

Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries.

Sara O Dionne1, Douglas F Lake, William J Grimes, Margaret H Smith.   

Abstract

Unlike HLA-A and HLA-B, few peptide epitope motifs have been reported for HLA-C molecules. However, a number of cytotoxic T-lymphocyte epitopes derived from tumor antigens that bind to HLA-C molecules have been described. Here we report peptide-binding motifs for both HLA-Cw6.02 and HLA-Cw7.01 molecules. Recombinant human HLA molecules were generated and used to screen combinatorial 9mer peptide libraries. Complexes of HLA molecules properly folded and associated with beta2-microglobulin and peptides were identified using a conformation-specific HLA class I antibody conjugated to alkaline phosphatase. In the presence of substrate, peptide beads can be readily isolated and microsequenced to determine peptide identity. Of the peptides that bound to HLA-Cw6.02 and HLA-Cw7.01, 19 and 18 peptides, respectively, were sequenced, allowing motif identification for each C allele. This is the first report of an HLA-Cw7.01 peptide motif and extends the findings of Falk et al. [(1993) Proc Natl Acad Sci USA 90:12005] for an HLA-Cw6.02 motif. Anchoring amino acids for the HLA-Cw6.02 motif were phenylalanine or tyrosine in position (P)1, arginine in P2, and an aliphatic/aromatic residue at P9. Anchoring residues for HLA-Cw7.01 were positively charged amino acids in P1 and P2. Unlike most other HLA molecules, we were unable to assign P9 an anchoring residue, and we suspect that HLA-Cw7.01 binds peptides in an unconventional manner. Additionally, preferred amino acids were identified for both molecules. Identification of HLA-Cw6.02 and HLA-Cw7.01 peptide-binding motifs makes a significant contribution to the C allele peptide-binding motifs and will allow investigators to predict, design, and test HLA-Cw6.02 and HLA-Cw7.01 engineered peptides for immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309347     DOI: 10.1007/s00251-004-0710-1

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  36 in total

1.  Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene.

Authors:  R Chiari; F Foury; E De Plaen; J F Baurain; J Thonnard; P G Coulie
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

2.  N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors.

Authors:  E Baba; R Erskine; J E Boyson; G B Cohen; D M Davis; P Malik; O Mandelboim; H T Reyburn; J L Strominger
Journal:  Hum Immunol       Date:  2000-12       Impact factor: 2.850

3.  A new type of synthetic peptide library for identifying ligand-binding activity.

Authors:  K S Lam; S E Salmon; E M Hersh; V J Hruby; W M Kazmierski; R J Knapp
Journal:  Nature       Date:  1991-11-07       Impact factor: 49.962

4.  Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702-associated epitope MAGE-A12:170-178.

Authors:  Maria P Bettinotti; Monica C Panelli; Erin Ruppe; Simone Mocellin; Giao Q Phan; Donald E White; Francesco M Marincola
Journal:  Int J Cancer       Date:  2003-06-10       Impact factor: 7.396

5.  Allele-specific peptide ligand motifs of HLA-C molecules.

Authors:  K Falk; O Rötzschke; B Grahovac; D Schendel; S Stevanović; V Gnau; G Jung; J L Strominger; H G Rammensee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

6.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Authors:  D N Garboczi; D T Hung; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

7.  Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens.

Authors:  C Castelli; P Tarsini; A Mazzocchi; F Rini; L Rivoltini; F Ravagnani; F Gallino; F Belli; G Parmiani
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

8.  Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.

Authors:  P van der Bruggen; J P Szikora; P Boël; C Wildmann; M Somville; M Sensi; T Boon
Journal:  Eur J Immunol       Date:  1994-09       Impact factor: 5.532

9.  The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells.

Authors:  D M Davis; O Mandelboim; I Luque; E Baba; J Boyson; J L Strominger
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

10.  A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma.

Authors:  B Van den Eynde; O Peeters; O De Backer; B Gaugler; S Lucas; T Boon
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more
  8 in total

1.  Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4.

Authors:  Irina Redchenko; Richard Harrop; Matthew G Ryan; Robert E Hawkins; Miles W Carroll
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule.

Authors:  Michael Rasmussen; Mikkel Harndahl; Anette Stryhn; Rachid Boucherma; Lise Lotte Nielsen; François A Lemonnier; Morten Nielsen; Søren Buus
Journal:  J Immunol       Date:  2014-10-13       Impact factor: 5.422

3.  HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.

Authors:  Rachid Boucherma; Hédia Kridane-Miledi; Romain Bouziat; Michael Rasmussen; Tanja Gatard; Francina Langa-Vives; Brigitte Lemercier; Annick Lim; Marion Bérard; Lbachir Benmohamed; Søren Buus; Ronald Rooke; François A Lemonnier
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

4.  Allele-specific cytokine responses at the HLA-C locus: implications for psoriasis.

Authors:  Christian Hundhausen; Anna Bertoni; Rose K Mak; Elisabetta Botti; Paola Di Meglio; Alex Clop; Ute Laggner; Sergio Chimenti; Adrian C Hayday; Jonathan N Barker; Richard C Trembath; Francesca Capon; Frank O Nestle
Journal:  J Invest Dermatol       Date:  2011-11-24       Impact factor: 8.551

5.  Melanocyte antigen triggers autoimmunity in human psoriasis.

Authors:  Akiko Arakawa; Katherina Siewert; Julia Stöhr; Petra Besgen; Song-Min Kim; Geraldine Rühl; Jens Nickel; Sigrid Vollmer; Peter Thomas; Stefan Krebs; Stefan Pinkert; Michael Spannagl; Kathrin Held; Claudia Kammerbauer; Robert Besch; Klaus Dornmair; Jörg C Prinz
Journal:  J Exp Med       Date:  2015-11-30       Impact factor: 14.307

6.  Peptide-specific engagement of the activating NK cell receptor KIR2DS1.

Authors:  Anaïs Chapel; Wilfredo F Garcia-Beltran; Angelique Hölzemer; Maja Ziegler; Sebastian Lunemann; Gloria Martrus; Marcus Altfeld
Journal:  Sci Rep       Date:  2017-05-25       Impact factor: 4.379

7.  TargetScore used to reveal potential targets of miRNA203 and miRNA-146a in psoriasis by integrating microRNA overexpression and microarray data.

Authors:  Hai-Xia Chen; Yan-Song Liu; Xiu-Jie Zhang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

8.  HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2+ NK cells in Lassa virus infection.

Authors:  Nadia Wauquier; Caroline Petitdemange; Nadine Tarantino; Christopher Maucourant; Moinya Coomber; Victor Lungay; James Bangura; Patrice Debré; Vincent Vieillard
Journal:  EBioMedicine       Date:  2019-01-30       Impact factor: 8.143

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.